{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T16:52:37Z","timestamp":1775235157537,"version":"3.50.1"},"reference-count":28,"publisher":"American Society for Microbiology","issue":"8","license":[{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2004,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p><jats:italic>Mycobacterium ulcerans<\/jats:italic>disease (Buruli ulcer) is a serious ulcerating skin disease which is common in many tropical countries. Standard treatment, by extensive excision and skin grafting, is not available in rural communities where the disease is common. We evaluated the efficacy and safety of treatment with topical nitrogen oxides. Thirty-seven patients with a clinical diagnosis of Buruli ulcer caused by<jats:italic>M. ulcerans<\/jats:italic>disease were randomly assigned to one of two groups. In one group, two creams containing sodium nitrite (6%, wt\/wt) or citric acid monohydrate (9%, wt\/wt) were applied daily for 6 weeks, while the other group received a placebo. In the second 6 weeks, both groups received the nitrogen oxide-generating combination of creams. Treatment was continued for another 4 weeks for patients whose ulcers were not healed after 12 weeks. The ulcer surface area was monitored by weekly tracings made by assessors blinded to the treatment. In the first 6 weeks, patients on sodium nitrite and citric acid monohydrate (group I, active treatment) showed a rapid decrease in ulcer size from 28.6 \u00b1 5.6 cm<jats:sup>2<\/jats:sup>(mean \u00b1 standard error) to 12.6 \u00b1 3.2 cm<jats:sup>2<\/jats:sup>, a decrease significantly greater than that in group II (from 15.3 \u00b1 3.1 to 11.7 \u00b1 3.7 cm<jats:sup>2<\/jats:sup>;<jats:italic>P<\/jats:italic>= 0.03). Five ulcers in the placebo group enlarged during this period, compared with one in the active group. In the second 6 weeks (both groups on active treatment), the rates of healing were similar for the two groups and there was a significant reduction in ulcer size in group II (previously on placebo) compared to the first 6 weeks. Yellow pigmentation of the skin, which disappeared 3 days after treatment was stopped, was the only side effect to date. We conclude that creams releasing nitrogen oxides increase the healing rate of ulcers caused by<jats:italic>M. ulcerans<\/jats:italic>infection with minimal adverse events. This is the first controlled trial of any form of therapy which demonstrates efficacy in treating this disease.<\/jats:p>","DOI":"10.1128\/aac.48.8.2866-2870.2004","type":"journal-article","created":{"date-parts":[[2004,7,23]],"date-time":"2004-07-23T18:45:20Z","timestamp":1090608320000},"page":"2866-2870","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":55,"title":["Pilot Randomized Double-Blind Trial of Treatment of<i>Mycobacterium ulcerans<\/i>Disease (Buruli Ulcer) with Topical Nitrogen Oxides"],"prefix":"10.1128","volume":"48","author":[{"given":"R.","family":"Phillips","sequence":"first","affiliation":[{"name":"Komfo Anokye Teaching Hospital and School of Medical Sciences, Kumasi, Ghana"},{"name":"St. George's Hospital Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Adjei","sequence":"additional","affiliation":[{"name":"Komfo Anokye Teaching Hospital and School of Medical Sciences, Kumasi, Ghana"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Lucas","sequence":"additional","affiliation":[{"name":"Department of Histopathology, St. Thomas's Hospital, London"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Benjamin","sequence":"additional","affiliation":[{"name":"Peninsula Medical School, St. Luke's Campus, Exeter, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Wansbrough-Jones","sequence":"additional","affiliation":[{"name":"Komfo Anokye Teaching Hospital and School of Medical Sciences, Kumasi, Ghana"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.4049\/jimmunol.147.5.1642","volume":"147","year":"1991","unstructured":"Adams, L. B., S. Franzblau, Z. Vavrin, J. B. Hibbs, Jr., and J. L. Krahenbuhl. 1991. l-Arginine-dependent macrophage effector functions inhibit metabolic activity of Mycobacterium leprae. J. Immunol.147:1642-1646.","journal-title":"J. Immunol."},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0035-9203(98)90977-4","volume":"92","year":"1998","unstructured":"Adjei, O., M. R. W. Evans, and A. Asiedu. 1998. Phenytoin in the treatment of Buruli ulcer. Trans. R. Soc. Trop. Med. Hyg.92:108-109.","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1998.59.1015"},{"key":"e_1_3_2_5_2","unstructured":"Asiedu K. R. Scherpbier and M. Raviglione (ed.). 2000. Buruli ulcer: Mycobacterium ulcerans infection. World Health Organization Geneva Switzerland."},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0598-615"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830230508"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0005-2728(99)00021-3"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.272.5260.414"},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S1201-9712(02)90138-4","volume":"6","year":"2002","unstructured":"Espey, D. K., G. Djomand, I. Diomande, M. Dosso, M. Z. Saki, J. M. Kanga, R. A. Spiegel, B. J. Marston, L. Gorelkin, W. M. Meyers, F. Portaels, M. S. Deming, and C. R. Horsburgh, Jr. 2002. A pilot study of treatment of Buruli ulcer with rifampin and dapsone. Int. J. Infect. Dis.6:60-65.","journal-title":"Int. J. Infect. Dis."},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119473"},{"key":"e_1_3_2_12_2","unstructured":"Grange J. 1996. Mycobacteria and human disease 2nd ed. Oxford University Press New York N.Y."},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0695-552"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.64.1.69-76.1996"},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0891-5849(93)90084-8","volume":"14","year":"1993","unstructured":"Klebanoff, S. J. 1993. Reactive nitrogen intermediates and antimicrobial activity: role of nitrite. Free Radical Biol. Med.14:351-360.","journal-title":"Free Radical Biol. Med."},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830211216"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/aem.46.1.198-202.1983"},{"key":"e_1_3_2_18_2","first-page":"2417","volume":"10","year":"1997","unstructured":"Nathan, C. 1997. Inducible nitric oxide synthase: what difference does it make? J. Clin. Investig.10:2417-2423.","journal-title":"J. Clin. Investig."},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.8.3130-3132.2004"},{"key":"e_1_3_2_20_2","first-page":"873","volume":"2","year":"1973","unstructured":"Revill, W. D., R. H. Morrow, M. C. Pike, and J. Ateng. 1973. A controlled trial of the treatment of Mycobacterium ulcerans infection with clofazimine. Lancet2:873-877.","journal-title":"Lancet"},{"key":"e_1_3_2_21_2","unstructured":"SAS Institute. 1996. SAS version 6.12. SAS Institute Cary N.C."},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0035-9203(99)90104-9"},{"key":"e_1_3_2_23_2","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(99)04095-7","volume":"354","year":"1999","unstructured":"Tucker, A. T., R. M. Pearson, E. D. Cooke, and N. Benjamin. 1999. Effect of nitric-oxide-generating system on microcirculatory blood flow in skin of patients with severe Raynaud's syndrome: a randomised trial. Lancet354:1670-1675.","journal-title":"Lancet"},{"key":"e_1_3_2_24_2","first-page":"408","volume":"375","year":"1995","unstructured":"Wei, X. Q., I. G. Charles, A. Smith, J. Ure, G. J. Feng, F. P. Huang, D. Xu, W. Muller, S. Moncada, and F. Y. Liew. 1995. Altered immune response in mice lacking inducible nitric oxide synthase. Nat. Med.375:408-411.","journal-title":"Nat. Med."},{"key":"e_1_3_2_25_2","first-page":"665","volume":"137","year":"1997","unstructured":"Weller, R. 1997. Nitric oxide: a newly discovered chemical transmitter in human skin. Br. J. Dermatol.137:665-672.","journal-title":"Br. J. Dermatol."},{"key":"e_1_3_2_26_2","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1046\/j.1365-2230.1999.00509.x","volume":"24","year":"1999","unstructured":"Weller, R. 1999. Nitric oxide, skin growth and differentiation: more questions than answers? Clin. Exp. Dermatol.24:388-391.","journal-title":"Clin. Exp. Dermatol."},{"key":"e_1_3_2_27_2","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0190-9622(98)70117-3","volume":"38","year":"1998","unstructured":"Weller, R., A. D. Ormerod, R. P. Hobson, and N. J. Benjamin. 1998. A randomized trial of acidified nitrite cream in the treatment of tinea pedis. J. Am. Acad. Dermatol.38:559-563.","journal-title":"J. Am. Acad. Dermatol."},{"key":"e_1_3_2_28_2","first-page":"569","volume":"134","year":"1996","unstructured":"Weller, R., A. Ormerod, and N. Benjamin. 1996. Nitric oxide generation measured directly from psoriatic plaques by chemiluminescence. Br. J. Dermatol.134:569.","journal-title":"Br. J. Dermatol."},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2672.2001.01291.x"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.48.8.2866-2870.2004","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.48.8.2866-2870.2004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T02:36:14Z","timestamp":1682735774000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.48.8.2866-2870.2004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["10.1128\/AAC.48.8.2866-2870.2004"],"URL":"https:\/\/doi.org\/10.1128\/aac.48.8.2866-2870.2004","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,8]]},"assertion":[{"value":"2003-12-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2004-04-26","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2004-08-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}